Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 7/20 | 1.00 |
| ▸ | DRD3 | P35462 | 7/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 6/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 6/20 | 1.00 |
| ▸ | DRD2 | P14416 | 6/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 5/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 5/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 5/20 | 1.00 |
| ▸ | HTR2A | P28223 | 5/20 | 1.00 |
| ▸ | HTR2C | P28335 | 5/20 | 1.00 |
| ▸ | HRH1 | P35367 | 5/20 | 1.00 |
| ▸ | HTR2B | P41595 | 4/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | HTR1A | P08908 | 4/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 3/20 | 1.00 |
| ▸ | HTR3A | P46098 | 3/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 3/20 | 1.00 |
| ▸ | ADRA1D | P25100 | 3/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 3/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pizotyline SCHEMBL29366884 | 1.00 | DRD1 (1.00) | DRD1DRD3CHRM2CHRM1DRD2 | |
| Pizotyline SCHEMBL8771138 | 1.00 | DRD1 (1.00) | DRD1DRD3CHRM2CHRM1DRD2 | |
| Pizotyline SCHEMBL11436430 | 0.99 | DRD1 (0.97) | DRD1DRD3CHRM2CHRM1DRD2 | |
| Pizotyline SCHEMBL1000901 | 0.89 | MAPK1 (1.00) | DRD1DRD3CHRM2CHRM1DRD2 | |
| Pizotyline SCHEMBL1000902 | 0.89 | MAPK1 (1.00) | DRD1DRD3CHRM2CHRM1DRD2 | |
| SCHEMBL7817056 | 0.86 | SETD7 (1.00) | DRD1DRD3CHRM2CHRM1DRD2 | |
| Pizotyline SCHEMBL365598 | 0.83 | CYP2D6 (1.00) | DRD1DRD3CHRM2CHRM1DRD2 | |
| SCHEMBL3044995 | 0.82 | DRD3 (0.70) | DRD1DRD3CHRM2CHRM1DRD2 | |
| SCHEMBL11601745 | 0.82 | MAPK1 (0.69) | DRD1DRD3CHRM2CHRM1DRD2 | |
| SCHEMBL21859441 | 0.82 | CHRM2 (0.69) | DRD1DRD3CHRM2CHRM1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5808 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4725483-A1 | COMBINATION COMPRISING AT LEAST ONE 5-HT2A RECEPTOR ANTAGONIST AND AT LEAST ONE 5-HT3 RECEPTOR ANTAGONIST AND ITS MEDICAL USE | Université de Bordeaux (FR) | 2026-04-15 | — | — | EP | claimed |
| US-20260083759-A1 | Combinations Comprising Psychedelics for the Treatment of Schizophrenia and Other Neuropsychiatric and Neurologic Disorders | HADASIT MED RES SERVICE (IL) | 2026-03-26 | — | — | US | claimed |
| US-20250295611-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS INC (US) | 2025-09-25 | — | — | US | claimed |
| EP-4154879-B1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NICOTINE WITHDRAWAL SYMPTOMS | KOREA INST SCI & TECH (KR) | 2025-09-10 | — | — | EP | claimed |
| US-20250263474-A1 | TREATING REFRACTORY MIGRAINE | TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) | 2025-08-21 | — | — | US | claimed |
| EP-4583858-A1 | COMBINATIONS COMPRISING PSYCHEDELICS FOR THE TREATMENT OF SCHIZOPHRENIA AND OTHER NEUROPSYCHIATRIC AND NEUROLOGIC DISORDERS | Hadasit Medical Research Services&Development Ltd. (IL) | 2025-07-16 | — | — | EP | claimed |
| US-20250213647-A1 | CHEMOKINE RECEPTORS AND ALPHA1 ADRENERGIC RECEPTORS/VASOPRESSIN RECEPTORS 1A HETEROMERS AS DRUG TARGETS FOR DISEASE | UNIVERSITY OF SOUTH FLORIDA | 2025-07-03 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20250170143-A1 | METHODS OF TREATING OCULAR FIBROTIC PATHOLOGIES | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2025-05-29 | — | — | US | claimed |
| CN-120044159-A | Polygonatum sibiricum medicinal material species identification method based on polygonatum sibiricum characteristic compound and application | 河北北方学院 | 2025-05-27 | — | — | CN | claimed |
| EP-1011656-A2 | A METHOD FOR TREATING TENSION-TYPE HEADACHE | Head Explorer ApS (DK) | 2000-06-28 | — | — | EP | claimed |
| JP-2000500446-A | — | — | 2000-01-18 | — | — | JP | claimed |
| US-5942503-A | Use of Epinastine for the treatment of pain | BOEHRINGER INDELHEIM KG (DE) | 1999-08-24 | — | — | US | claimed |
| CN-1202111-A | Use of epinastine in the treatment of pain | BOEHRINGER INGELHEIM KG (DE) | 1998-12-16 | — | — | CN | claimed |
| EP-0861081-A1 | USE OF EPINASTINE IN THE TREATMENT OF PAIN | BOEHRINGER INGELHEIM KG (DE) | 1998-09-02 | — | — | EP | claimed |
| WO-1998019674-A2 | A METHOD FOR TREATING TENSION-TYPE HEADACHE | HEAD EXPLORER APS (DK) | 1998-05-14 | — | — | WO | claimed |
| WO-1997041878-A1 | TREATMENT OF MOOD DISORDERS WITH A GROWTH HORMONE SECRETAGOGUE | MERCK & CO., INC. (US) | 1997-11-13 | — | — | WO | claimed |
| WO-1997017971-A1 | USE OF EPINASTINE IN THE TREATMENT OF PAIN | BOEHRINGER INGELHEIM KG (DE) | 1997-05-22 | — | — | WO | claimed |
| EP-0487674-B1 | INJECTABLE SLOW-RELEASE GALENICAL | APLICACIONES FARMACEUTICAS (MX) | 1995-01-25 | — | — | EP | claimed |
| US-4444778-A | ANTISEROTONINE AGENTS | COUGHLIN SHAUN R | 1984-04-24 | — | — | US | claimed |